Haberler: Kovid-19

Kovid-19

İçinde

("Covid 19","Kovid 19","Koronavirüs","Korona virüs","Biontech","Sinovac","Delta ","Lambda ","Covid19","Kovid19","Covid-19","Kovid-19","Omicron ","Omikron ")

kelimelerinden biri ile,

(" aşı","vaccine","varyant","variant","pandemi","vaka "," dalga","pandemic","salgın")

kelimelerinden birinin aynı anda geçtiği haberler

Çarşamba, 25 Mayıs 2022, 12:06 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022 This report describes effectiveness of mRNA COVID-19 vaccination in preventing COVID-19 associated invasive mechanical ventilation and death after receiving 2 or 3 vaccine doses. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=625714

Çarşamba, 25 Mayıs 2022, 12:06 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022 This report describes adult COVID-19 hospitalization rates by race/ethnicity during SARS-CoV-2 Delta and Omicron predominance. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=625715

Çarşamba, 25 Mayıs 2022, 12:06 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic - 41 PEPFAR-Supported Countries, 2020 This report describes programmatic gains of HIV treatment during the pandemic. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=642931

Çarşamba, 25 Mayıs 2022, 12:06 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022 This report describes the Advisory Committee on Immunization Practices' recommendation for use of the Moderna COVID-19 vaccine in adults. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=622515

Çarşamba, 25 Mayıs 2022, 12:06 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Hospitalization of Infants and Children Aged 0-4 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022 This report describes COVID-19 hospitalization rates among infants and children aged 0-4 years, including during Omicron variant predominance. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=613117

Çarşamba, 25 Mayıs 2022, 12:06 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022 This report describes vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine as effective in protecting against Omicron infection among children and adolescents. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=603187

Çarşamba, 25 Mayıs 2022, 12:06 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 2021-January 2022 This report describes COVID-19 vaccine provider access and vaccination coverage among U.S. children aged 5-11 years. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=600326

Çarşamba, 25 Mayıs 2022, 12:06 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households - Four U.S. Jurisdictions, November 2021-February 2022 This report describes how Omicron infection resulted in high transmission among household contacts. Prevention strategies are important to reduce transmission in households. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=564942

Çarşamba, 25 Mayıs 2022, 12:06 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022 This report describes safety monitoring after a Pfizer-BioNTech booster vaccination among children and adolescents aged 12-17 years. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=575231

Çarşamba, 25 Mayıs 2022, 12:06 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022 This report describes mRNA COVID-19 vaccine effectiveness in preventing emergency department and urgent care encounters as well as hospitalizations among children and adolescents. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=575259